Literature DB >> 9417645

Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma.

P Brousset, F Meggetto, M Attal, G Delsol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9417645

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

1.  Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.

Authors:  G Gaidano; E Castaños-Velez; P Biberfeld
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

2.  Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma.

Authors:  L Pan; L Milligan; J Michaeli; E Cesarman; D M Knowles
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

3.  Hypothesis. HHV-8 in multiple myeloma: is this the first paracrine model of human tumorigenesis and do Koch's postulates apply?

Authors:  J J O'Leary; I Silva; V Uhlmann; M Prasad; K Luttich; A Maffei; S Picton
Journal:  Mol Pathol       Date:  1998-08

Review 4.  Human herpesvirus 8 in hematologic diseases.

Authors:  G Mikala; J Xie; G Berencsi; C Kiss; I Márton; G Domján; I Vályi-Nagy
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

5.  Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.

Authors:  X Wan; H Wang; J Nicholas
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 6.  Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes.

Authors:  Jian-Chao Zong; Ravit Arav-Boger; Donald J Alcendor; Gary S Hayward
Journal:  J Clin Virol       Date:  2007-08-14       Impact factor: 3.168

7.  Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate.

Authors:  H Hjalgrim; M Frisch; M Melbye
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.